Exact Mass: 393.1358
Exact Mass Matches: 393.1358
Found 114 metabolites which its exact mass value is equals to given mass value 393.1358
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Tifluadom
C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Same as: D02694
Fruquintinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
(S)-N1-(2-(tert-butyl)-4-methyl-[4,5-bithiazol]-2-yl)pyrrolidine-1,2-dicarboxamide
N-Hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](3-picolyl)amino]-3-methylbutanamide hydrochloride
4-(2-Aminoethylamino)-3-[bis(carboxymethyl)amino]-3-(carboxymethyl)hexanedioic acid
Ala Cys Asn Ser
Ala Cys Ser Asn
Ala Asn Cys Ser
Ala Asn Ser Cys
Ala Ser Cys Asn
Ala Ser Asn Cys
Cys Ala Asn Ser
Cys Ala Ser Asn
Cys Gly Asn Thr
Cys Gly Gln Ser
Cys Gly Ser Gln
Cys Gly Thr Asn
Cys Asn Ala Ser
Cys Asn Gly Thr
Cys Asn Ser Ala
Cys Asn Thr Gly
Cys Gln Gly Ser
Cys Gln Ser Gly
Cys Ser Ala Asn
Cys Ser Gly Gln
Cys Ser Asn Ala
Cys Ser Gln Gly
Cys Thr Gly Asn
Cys Thr Asn Gly
Gly Cys Asn Thr
Gly Cys Gln Ser
Gly Cys Ser Gln
Gly Cys Thr Asn
Gly Asn Cys Thr
Gly Asn Thr Cys
Gly Gln Cys Ser
Gly Gln Ser Cys
Gly Ser Cys Gln
Gly Ser Gln Cys
Gly Thr Cys Asn
Gly Thr Asn Cys
Asn Ala Cys Ser
Asn Ala Ser Cys
Asn Cys Ala Ser
Asn Cys Gly Thr
Asn Cys Ser Ala
Asn Cys Thr Gly
Asn Gly Cys Thr
Asn Gly Thr Cys
Asn Ser Ala Cys
Asn Ser Cys Ala
Asn Thr Cys Gly
Asn Thr Gly Cys
Gln Cys Gly Ser
Gln Cys Ser Gly
Gln Gly Cys Ser
Gln Gly Ser Cys
Gln Ser Cys Gly
Gln Ser Gly Cys
Ser Ala Cys Asn
Ser Ala Asn Cys
Ser Cys Ala Asn
Ser Cys Gly Gln
Ser Cys Asn Ala
Ser Cys Gln Gly
Ser Gly Cys Gln
Ser Gly Gln Cys
Ser Asn Ala Cys
Ser Asn Cys Ala
Ser Gln Cys Gly
Ser Gln Gly Cys
Thr Cys Gly Asn
Thr Cys Asn Gly
Thr Gly Cys Asn
Thr Gly Asn Cys
Thr Asn Cys Gly
Thr Asn Gly Cys
Pentetic acid
D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents D020011 - Protective Agents > D000931 - Antidotes
2,3,5-Tri-O-acetyladenosine
2’,3’,5’-Tri-O-acetyl adenosine is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1].
methyl 2-[(3-cyanobenzoyl)amino]-3-(3-methoxypropyl)imidazo[4,5-b]pyridine-6-carboxylate
1-(3,5-DIMETHYL-4-ETHYL-PYRROL-2-YL)-3-(3,5-DIMETHYL-4-ETHYL-PYRROLIUM-2-YLIDENE)-CYCLOBUTEN-2-ONE-4-OLATE
O-[BIS(4-METHOXYPHENYL)PHOSPHINYL]-N-(TERT-BUTOXYCARBONYL)HYDROXYLAMINE
N-Hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](3-picolyl)amino]-3-methylbutanamide hydrochloride
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors
N-[4-(4-morpholinyl)phenyl]-5-(2-nitrophenyl)-2-furancarboxamide
N-(3-imidazol-1-ylpropyl)-2-[(4-nitrobenzoyl)amino]benzamide
2-[1-[[[(4-Methoxyphenyl)-oxomethyl]amino]-sulfanylidenemethyl]-3-oxo-2-piperazinyl]acetic acid propan-2-yl ester
N-{(E)-[2,4,6-trioxo-1-(2,4,6-trimethylphenyl)tetrahydropyrimidin-5(2H)-ylidene]methyl}pyridine-4-carbohydrazide
(3E)-3-{2-[(4-methoxyphenyl)carbonyl]hydrazinylidene}-N-[3-(trifluoromethyl)phenyl]butanamide
(2S,3R,4S)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2S,3S,4S)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2S,3S,4R)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2R,3R,4R)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2R,3S,4S)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2R,3S,4R)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2S,3R,4R)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
Tifluadom
C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Same as: D02694
Agomelatine (L(+)-Tartaric acid)
Agomelatine L(+)-Tartaric acid (S-20098 L(+)-Tartaric acid) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively[1]. Agomelatine L(+)-Tartaric acid is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively[2].
AKT Kinase Inhibitor (hydrochloride)
AKT Kinase Inhibitor hydrochloride is an Akt kinase inhibitor with anti-tumor activity[1]. AKT Kinase Inhibitor (hydrochloride) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
SCD1 inhibitor-3
SCD1 inhibitor-3 is a safe, potent and orally active SCD1 inhibitor. SCD1 inhibitor-3 can be used for the research of metabolic diseases such as obesity, type II diabetes and dyslipidemia, as well as skin diseases, acne and cancer[1].